Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update

As the COVID-19 pandemic evolves, new effective treatment options are essential for reducing morbidity and mortality as well as the strain placed on the healthcare system. Since publication of our initial review on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients, interest in HBOT...

Full description

Saved in:
Bibliographic Details
Published in:Diving and hyperbaric medicine 2022-06, Vol.52 (2), p.126-135
Main Authors: Boet, Sylvain, Etherington, Cole, Ghanmi, Nibras, Ioudovski, Paul, Tricco, Andrea C, Sikora, Lindsey, Katznelson, Rita
Format: Article
Language:English
Subjects:
COVID-19 - therapy
Humans
Hyperbaric Oxygenation - adverse effects
Oxygen
Pandemics
Systemic Review
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c396t-bb75b5462ecfeffbf965eab7e700ef8728de3d7189a27dad97195712383f52473
cites
container_end_page 135
container_issue 2
container_start_page 126
container_title Diving and hyperbaric medicine
container_volume 52
creator Boet, Sylvain
Etherington, Cole
Ghanmi, Nibras
Ioudovski, Paul
Tricco, Andrea C
Sikora, Lindsey
Katznelson, Rita
description As the COVID-19 pandemic evolves, new effective treatment options are essential for reducing morbidity and mortality as well as the strain placed on the healthcare system. Since publication of our initial review on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients, interest in HBOT for COVID-19 has grown and additional studies have been published. For this living systematic review update the previously published search strategy (excluding Google Scholar) was adopted with an extension from 01 February 2021 to 01 April 2022. Study inclusion criteria, data extraction, risk of bias estimation and dispute resolution methods were repeated. Two new studies enrolling 127 patients were included in this update, taking the total to eight studies with 224 patients. Both new studies were randomised controlled trials, one at moderate and one at high risk of bias. Across these eight studies, 114 patients were treated with HBOT. All reported improved clinical outcomes without observation of any serious adverse events. Meta-analysis remained unjustified given the high heterogeneity between studies and incomplete reporting. This updated living systematic review provides further evidence on the safety and effectiveness of HBOT to treat acute hypoxaemic COVID-19 patients.
doi_str_mv 10.28920/dhm52.2.126-135
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9522603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2680239086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-bb75b5462ecfeffbf965eab7e700ef8728de3d7189a27dad97195712383f52473</originalsourceid><addsrcrecordid>eNpVkc2LFDEQxYMo7rh69yQ5eukxqUy-PAgyrrqwsBf1GtLdlZlIf22SHu3_3mZnXfRUFPXeqwc_Ql5ztgVjgb1rj72ELWw5qIoL-YRsAJit-M7yp2TDjRCVkFxdkBc5_2RM7oSSz8mFkFoAGLkhd1chxMY3C_VDS7MPWBY6BnpcJky1T7Gh4-_lgAMtCX3pcSi0jOeF7m9_XH-quKXTgHM_DtG_p5528RSHA81LLtj7siYkPEX8Reep9QVfkmfBdxlfPcxL8v3z1bf91-rm9sv1_uNN1QirSlXXWtZypwCbgCHUwSqJvtaoGcNgNJgWRau5sR5061uruZWagzAiSNhpcUk-nHOnue6xbdbmyXduSrH3aXGjj-7_yxCP7jCenJUAiok14O1DQBrvZszF9TE32HV-wHHODpRhICwzapWys7RJY84Jw-Mbztw9KXdPyoFbSbmV1Gp582-9R8NfNOIPGmWR5A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2680239086</pqid></control><display><type>article</type><title>Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update</title><source>Open Access: PubMed Central</source><creator>Boet, Sylvain ; Etherington, Cole ; Ghanmi, Nibras ; Ioudovski, Paul ; Tricco, Andrea C ; Sikora, Lindsey ; Katznelson, Rita</creator><creatorcontrib>Boet, Sylvain ; Etherington, Cole ; Ghanmi, Nibras ; Ioudovski, Paul ; Tricco, Andrea C ; Sikora, Lindsey ; Katznelson, Rita ; Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada ; Department of Public Health Sciences, Faculty of Health Sciences, Queens University, Ontario, Canada ; Francophone Affairs, Faculty of Medicine, University of Ottawa, Ottawa, Canada ; Queen’s Collaboration for Health Care Quality: A JBI Centre of Excellence, Ontario, Canada ; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada ; Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada ; Li Ka Shing Knowledge Institute, St Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada ; Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada ; Health Sciences Library, University of Ottawa, Ottawa, Canada</creatorcontrib><description>As the COVID-19 pandemic evolves, new effective treatment options are essential for reducing morbidity and mortality as well as the strain placed on the healthcare system. Since publication of our initial review on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients, interest in HBOT for COVID-19 has grown and additional studies have been published. For this living systematic review update the previously published search strategy (excluding Google Scholar) was adopted with an extension from 01 February 2021 to 01 April 2022. Study inclusion criteria, data extraction, risk of bias estimation and dispute resolution methods were repeated. Two new studies enrolling 127 patients were included in this update, taking the total to eight studies with 224 patients. Both new studies were randomised controlled trials, one at moderate and one at high risk of bias. Across these eight studies, 114 patients were treated with HBOT. All reported improved clinical outcomes without observation of any serious adverse events. Meta-analysis remained unjustified given the high heterogeneity between studies and incomplete reporting. This updated living systematic review provides further evidence on the safety and effectiveness of HBOT to treat acute hypoxaemic COVID-19 patients.</description><identifier>ISSN: 1833-3516</identifier><identifier>EISSN: 2209-1491</identifier><identifier>DOI: 10.28920/dhm52.2.126-135</identifier><identifier>PMID: 35732285</identifier><language>eng</language><publisher>Australia: The Journal of the South Pacific Underwater Medicine Society and the European Underwater and Baromedical Society</publisher><subject>COVID-19 - therapy ; Humans ; Hyperbaric Oxygenation - adverse effects ; Oxygen ; Pandemics ; Systemic Review ; Treatment Outcome</subject><ispartof>Diving and hyperbaric medicine, 2022-06, Vol.52 (2), p.126-135</ispartof><rights>Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.</rights><rights>Copyright: © 2022 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-bb75b5462ecfeffbf965eab7e700ef8728de3d7189a27dad97195712383f52473</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522603/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522603/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35732285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boet, Sylvain</creatorcontrib><creatorcontrib>Etherington, Cole</creatorcontrib><creatorcontrib>Ghanmi, Nibras</creatorcontrib><creatorcontrib>Ioudovski, Paul</creatorcontrib><creatorcontrib>Tricco, Andrea C</creatorcontrib><creatorcontrib>Sikora, Lindsey</creatorcontrib><creatorcontrib>Katznelson, Rita</creatorcontrib><creatorcontrib>Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada</creatorcontrib><creatorcontrib>Department of Public Health Sciences, Faculty of Health Sciences, Queens University, Ontario, Canada</creatorcontrib><creatorcontrib>Francophone Affairs, Faculty of Medicine, University of Ottawa, Ottawa, Canada</creatorcontrib><creatorcontrib>Queen’s Collaboration for Health Care Quality: A JBI Centre of Excellence, Ontario, Canada</creatorcontrib><creatorcontrib>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada</creatorcontrib><creatorcontrib>Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada</creatorcontrib><creatorcontrib>Li Ka Shing Knowledge Institute, St Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada</creatorcontrib><creatorcontrib>Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada</creatorcontrib><creatorcontrib>Health Sciences Library, University of Ottawa, Ottawa, Canada</creatorcontrib><title>Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update</title><title>Diving and hyperbaric medicine</title><addtitle>Diving Hyperb Med</addtitle><description>As the COVID-19 pandemic evolves, new effective treatment options are essential for reducing morbidity and mortality as well as the strain placed on the healthcare system. Since publication of our initial review on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients, interest in HBOT for COVID-19 has grown and additional studies have been published. For this living systematic review update the previously published search strategy (excluding Google Scholar) was adopted with an extension from 01 February 2021 to 01 April 2022. Study inclusion criteria, data extraction, risk of bias estimation and dispute resolution methods were repeated. Two new studies enrolling 127 patients were included in this update, taking the total to eight studies with 224 patients. Both new studies were randomised controlled trials, one at moderate and one at high risk of bias. Across these eight studies, 114 patients were treated with HBOT. All reported improved clinical outcomes without observation of any serious adverse events. Meta-analysis remained unjustified given the high heterogeneity between studies and incomplete reporting. This updated living systematic review provides further evidence on the safety and effectiveness of HBOT to treat acute hypoxaemic COVID-19 patients.</description><subject>COVID-19 - therapy</subject><subject>Humans</subject><subject>Hyperbaric Oxygenation - adverse effects</subject><subject>Oxygen</subject><subject>Pandemics</subject><subject>Systemic Review</subject><subject>Treatment Outcome</subject><issn>1833-3516</issn><issn>2209-1491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkc2LFDEQxYMo7rh69yQ5eukxqUy-PAgyrrqwsBf1GtLdlZlIf22SHu3_3mZnXfRUFPXeqwc_Ql5ztgVjgb1rj72ELWw5qIoL-YRsAJit-M7yp2TDjRCVkFxdkBc5_2RM7oSSz8mFkFoAGLkhd1chxMY3C_VDS7MPWBY6BnpcJky1T7Gh4-_lgAMtCX3pcSi0jOeF7m9_XH-quKXTgHM_DtG_p5528RSHA81LLtj7siYkPEX8Reep9QVfkmfBdxlfPcxL8v3z1bf91-rm9sv1_uNN1QirSlXXWtZypwCbgCHUwSqJvtaoGcNgNJgWRau5sR5061uruZWagzAiSNhpcUk-nHOnue6xbdbmyXduSrH3aXGjj-7_yxCP7jCenJUAiok14O1DQBrvZszF9TE32HV-wHHODpRhICwzapWys7RJY84Jw-Mbztw9KXdPyoFbSbmV1Gp582-9R8NfNOIPGmWR5A</recordid><startdate>20220630</startdate><enddate>20220630</enddate><creator>Boet, Sylvain</creator><creator>Etherington, Cole</creator><creator>Ghanmi, Nibras</creator><creator>Ioudovski, Paul</creator><creator>Tricco, Andrea C</creator><creator>Sikora, Lindsey</creator><creator>Katznelson, Rita</creator><general>The Journal of the South Pacific Underwater Medicine Society and the European Underwater and Baromedical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220630</creationdate><title>Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update</title><author>Boet, Sylvain ; Etherington, Cole ; Ghanmi, Nibras ; Ioudovski, Paul ; Tricco, Andrea C ; Sikora, Lindsey ; Katznelson, Rita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-bb75b5462ecfeffbf965eab7e700ef8728de3d7189a27dad97195712383f52473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>COVID-19 - therapy</topic><topic>Humans</topic><topic>Hyperbaric Oxygenation - adverse effects</topic><topic>Oxygen</topic><topic>Pandemics</topic><topic>Systemic Review</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boet, Sylvain</creatorcontrib><creatorcontrib>Etherington, Cole</creatorcontrib><creatorcontrib>Ghanmi, Nibras</creatorcontrib><creatorcontrib>Ioudovski, Paul</creatorcontrib><creatorcontrib>Tricco, Andrea C</creatorcontrib><creatorcontrib>Sikora, Lindsey</creatorcontrib><creatorcontrib>Katznelson, Rita</creatorcontrib><creatorcontrib>Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada</creatorcontrib><creatorcontrib>Department of Public Health Sciences, Faculty of Health Sciences, Queens University, Ontario, Canada</creatorcontrib><creatorcontrib>Francophone Affairs, Faculty of Medicine, University of Ottawa, Ottawa, Canada</creatorcontrib><creatorcontrib>Queen’s Collaboration for Health Care Quality: A JBI Centre of Excellence, Ontario, Canada</creatorcontrib><creatorcontrib>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada</creatorcontrib><creatorcontrib>Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada</creatorcontrib><creatorcontrib>Li Ka Shing Knowledge Institute, St Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada</creatorcontrib><creatorcontrib>Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada</creatorcontrib><creatorcontrib>Health Sciences Library, University of Ottawa, Ottawa, Canada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diving and hyperbaric medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boet, Sylvain</au><au>Etherington, Cole</au><au>Ghanmi, Nibras</au><au>Ioudovski, Paul</au><au>Tricco, Andrea C</au><au>Sikora, Lindsey</au><au>Katznelson, Rita</au><aucorp>Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada</aucorp><aucorp>Department of Public Health Sciences, Faculty of Health Sciences, Queens University, Ontario, Canada</aucorp><aucorp>Francophone Affairs, Faculty of Medicine, University of Ottawa, Ottawa, Canada</aucorp><aucorp>Queen’s Collaboration for Health Care Quality: A JBI Centre of Excellence, Ontario, Canada</aucorp><aucorp>Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada</aucorp><aucorp>Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada</aucorp><aucorp>Li Ka Shing Knowledge Institute, St Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada</aucorp><aucorp>Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada</aucorp><aucorp>Health Sciences Library, University of Ottawa, Ottawa, Canada</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update</atitle><jtitle>Diving and hyperbaric medicine</jtitle><addtitle>Diving Hyperb Med</addtitle><date>2022-06-30</date><risdate>2022</risdate><volume>52</volume><issue>2</issue><spage>126</spage><epage>135</epage><pages>126-135</pages><issn>1833-3516</issn><eissn>2209-1491</eissn><abstract>As the COVID-19 pandemic evolves, new effective treatment options are essential for reducing morbidity and mortality as well as the strain placed on the healthcare system. Since publication of our initial review on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients, interest in HBOT for COVID-19 has grown and additional studies have been published. For this living systematic review update the previously published search strategy (excluding Google Scholar) was adopted with an extension from 01 February 2021 to 01 April 2022. Study inclusion criteria, data extraction, risk of bias estimation and dispute resolution methods were repeated. Two new studies enrolling 127 patients were included in this update, taking the total to eight studies with 224 patients. Both new studies were randomised controlled trials, one at moderate and one at high risk of bias. Across these eight studies, 114 patients were treated with HBOT. All reported improved clinical outcomes without observation of any serious adverse events. Meta-analysis remained unjustified given the high heterogeneity between studies and incomplete reporting. This updated living systematic review provides further evidence on the safety and effectiveness of HBOT to treat acute hypoxaemic COVID-19 patients.</abstract><cop>Australia</cop><pub>The Journal of the South Pacific Underwater Medicine Society and the European Underwater and Baromedical Society</pub><pmid>35732285</pmid><doi>10.28920/dhm52.2.126-135</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1833-3516
ispartof Diving and hyperbaric medicine, 2022-06, Vol.52 (2), p.126-135
issn 1833-3516
2209-1491
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9522603
source Open Access: PubMed Central
subjects COVID-19 - therapy
Humans
Hyperbaric Oxygenation - adverse effects
Oxygen
Pandemics
Systemic Review
Treatment Outcome
title Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T05%3A39%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20hyperbaric%20oxygen%20treatment%20to%20treat%20COVID-19%20pneumonia:%20a%20living%20systematic%20review%20update&rft.jtitle=Diving%20and%20hyperbaric%20medicine&rft.au=Boet,%20Sylvain&rft.aucorp=Department%20of%20Anesthesiology%20and%20Pain%20Medicine,%20The%20Ottawa%20Hospital,%20Ottawa,%20Canada&rft.date=2022-06-30&rft.volume=52&rft.issue=2&rft.spage=126&rft.epage=135&rft.pages=126-135&rft.issn=1833-3516&rft.eissn=2209-1491&rft_id=info:doi/10.28920/dhm52.2.126-135&rft_dat=%3Cproquest_pubme%3E2680239086%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c396t-bb75b5462ecfeffbf965eab7e700ef8728de3d7189a27dad97195712383f52473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2680239086&rft_id=info:pmid/35732285&rfr_iscdi=true